Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |